Coronavirus Vaccine Problems News ArticlesExcerpts of key news articles on coronavirus vaccine problems
In autumn 2020 Pfizer's chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. "As I've said before, we are operating at the speed of science," Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States. But, for researchers who were testing Pfizer's vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer's pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails. Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues.
Note: Yet every major media proudly announces "brought to you by Pfizer." Learn about Brianne Dressen, Ph.D., a volunteer for early COVID vaccines clinical trials who ended up with serious adverse effects the evening of the shot and was later hospitalized, yet then the study sponsors did not follow up with her. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma corruption from reliable major media sources.
Existing surveillance studies are not designed to reliably estimate life-threatening event or vaccine-induced fatality rates (VFR). Here, regional variation in vaccination rates was used to predict all-cause mortality and non-COVID deaths in subsequent time periods using two independent, publicly available datasets from the US and Europe. Results [suggest] 146K to 187K vaccine-associated US deaths between February and August, 2021. Comparing our estimate with the CDC-reported VFR (0.002%) suggests VAERS deaths are underreported by a factor of 20, consistent with known VAERS under-ascertainment bias. Comparing our age-stratified VFRs with published age-stratified coronavirus infection fatality rates (IFR) suggests the risks of COVID vaccines and boosters outweigh the benefits in children, young adults, and older adults with low occupational risk or previous coronavirus exposure. There is little to no evidence that vaccines reduce community spread and transmission. Vaccine mandates in workplaces, colleges, schools and elsewhere are ill-advised. The mandates are not based on sound science given the relatively low COVID risk in healthy middle-aged and young adults and growing evidence base for alternative prevention and early treatment options for COVID.
Note: See this webpage for information on the author of this study. Why has the media been all but silent on deaths and injuries from the vaccines? Read hundreds of personal stories of severe vaccine injury and death that are not being reported. And explore an excellent website which presents official VAERS information and in easily understandable format. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Massachusetts health officials on Tuesday reported ... 290 more deaths in people with breakthrough cases. In the last week, 27,530 new breakthrough cases - infections in people who have been vaccinated - were reported, with 555 more vaccinated people hospitalized over the period. It's a 40% drop in the rate of new breakthrough cases in Massachusetts - the previous week saw 46,092 new COVID infections in vaccinated people. On Tuesday ... there were 127 new deaths reported -- a statistic that includes three days because of the weekend -- bringing the death toll to 21,546. The seven-day average test positivity stands at 7.13%. In December, Massachusetts Department of Public Health officials released a study that found that 97% of breakthrough cases in the state did not become severely ill and rarely led to deaths, especially among young people. Massachusetts' COVID metrics, tracked on the Department of Public Health's interactive coronavirus dashboard, have been trending downward after spiking to heights not seen since previous surges, a peak thought to be driven at least in part by the omicron variant.
Note: As of Jan. 31, 2022, Massachusetts had a total of 21,546 COVID deaths as reported above. Their first COVID death was on Mar. 20, 2020. So over the 97 weeks since the start of the pandemic, they averaged 222 deaths a week. Yet in the last week of January 2022, this NBC article reports 290 breakthrough deaths. So the number of deaths among the vaccinated in that one week was greater than the average weekly number of deaths for the whole pandemic. Weren't these vaccines supposed to be 90% effective or more?
Microchip technology invented by Swedish startup company "Epicenter" is now being presented as a possible way to carry around a COVID-19 vaccine passport under a person's skin, according to a viral video. "Beep boop beep: Your vaccination record has been verified," says the caption of the video. "Imagine showing your COVID-19 passport with just a flash of your arm," the video says at its beginning, showing a person holding out their arm and scanning it with a mobile phone. The video explains the microchip uses pre-existing technology the startup company was already developing to employ "near-field communication" (NFC) and send data to any compatible device. Smartphones are listed as an example of a possible data receiver. "Implants are a very versatile technology that can be used for many different things," says Epicenter's Chief Disruption Officer Hannes Sjoblad in the video. "Right now it is very convenient to have a COVID passport always accessible on your implant." A microchip, about the size of a grain of rice, can be embedded under a person's skin, either under the arm or between the pointer finger and thumb, according to Sjoblad. After the chip is implanted, data such as a vaccine passport can be stored on it using NFC-compatible devices. There is pushback on implants from lawmakers, advocacy groups, and the public. Hannes Sjoblad reportedly organized "transplant parties" for his employees starting in 2014, where they would gather in a fun, social setting to get chips embedded into themselves.
Note: According to this article, "At the beginning of December, Sweden enacted new rules requiring individuals to have a passport at all events with more than 100 people. Following that announcement, the number of people who got microchips inserted under their skin rose: around 6,000 people in Sweden have so far had a chip inserted in their hands." For more along these lines, see concise summaries of deeply revealing news articles on microchip implants from reliable major media sources.
One remarkable aspect of the Covid-19 pandemic has been how often unpopular scientific ideas, from the lab-leak theory to the efficacy of masks, were initially dismissed, even ridiculed, only to resurface later. Another reversal in thinking may be imminent. Some scientists have raised concerns that the safety risks of Covid-19 vaccines have been underestimated. But the politics of vaccination has relegated their concerns to the outskirts of scientific thinking. The Vaccine Adverse Event Reporting System, or Vaers ... is a database that allows Americans to document adverse events that occur after receiving a vaccine. Vaers data for Covid-19 vaccines shows an interesting pattern. Among the 310 million Covid-19 vaccines administered, several adverse events are reported at high rates in the days immediately following vaccination, then drop sharply thereafter. The silence around these potential signals of harm reflects the policy surrounding Covid-19 vaccines. The stigma of such concerns is bad for scientific integrity and could harm patients. Four serious adverse events follow this arc, according to data directly from Vaers: low platelet count (thrombocytopenia); non-infectious myocarditis or inflammation of the heart, especially in those under 30; deep vein thrombosis. The implication is that the risks of a Covid-19 vaccine may outweigh the benefits for some low-risk populations, such as children, young adults, and people who have recovered from Covid-19.
Note: This article is also available here. Read a revealing article on how the WHO is flip flopping on the safety of vaccines for children. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Last year, racing to develop a vaccine in record time, Pfizer made a big decision: Unlike several rival manufacturers, which vowed to forgo profits on their shots during the Covid-19 pandemic, Pfizer planned to profit on its vaccine. On Tuesday, the company announced just how much money the shot is generating. The vaccine brought in $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue, Pfizer reported. The vaccine was, far and away, Pfizer's biggest source of revenue. The company did not disclose the profits it derived from the vaccine, but it reiterated its previous prediction that its profit margins on the vaccine would be in the high 20 percent range. That would translate into roughly $900 million in pretax vaccine profits in the first quarter. The company's vaccine is disproportionately reaching the world's rich – an outcome, so far at least, at odds with its chief executive's pledge to ensure that poorer countries "have the same access as the rest of the world" to a vaccine that is highly effective at preventing Covid-19. As of mid-April, wealthy countries had secured more than 87 percent of the more than 700 million doses of Covid-19 vaccines dispensed worldwide, while poor countries had received only 0.2 percent. Pfizer has kept the profitability of its vaccine sales opaque. The United States, for example, is paying $19.50 for each Pfizer dose. Israel agreed to pay Pfizer about $30 per dose.
Note: If Pfizer is truly concerned about global health, why are they reaping such huge profits when other companies were willing to forgo profits. And why are they not helping the economically disadvantaged countries? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma profiteering from reliable major media sources.
AstraZeneca may have included "outdated information" in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot. In an extraordinary rebuke, just hours after AstraZeneca on Monday announced its vaccine worked well in the U.S. study, an independent panel that oversees the study scolded the company for cherry-picking data, according to a senior administration official. The panel wrote to AstraZeneca and U.S. health leaders that it was concerned the company chose to use data that was outdated and potentially misleading instead of the most recent and complete findings. The NIH's Dr. Anthony Fauci told ABC's "Good Morning America" that the incident "really is what you call an unforced error" and that he expects the discrepancy to be straightened out. But that nitty-gritty seldom is seen by the public, something now exposed by the extraordinary microscope being applied to development of the world's COVID-19 vaccines. The vaccine is used widely in Britain, across the European continent and in other countries, but its rollout was troubled by inconsistent study reports about its effectiveness, and then last week a scare about blood clots that had some countries temporarily pausing inoculations. Company executives refused repeated requests from reporters to provide a breakdown of the 141 COVID-19 cases it was using to make the case for the shot's effectiveness.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
As the new Coronavirus spreads illness, death, and catastrophe around the world, virtually no economic sector has been spared from harm. Yet amid the mayhem ... one industry is not only surviving, it is profiting handsomely. "Pharmaceutical companies view Covid-19 as a once-in-a-lifetime business opportunity," said Gerald Posner, author of "Pharma: Greed, Lies, and the Poisoning of America." The world needs ... treatments and vaccines and, in the U.S., tests. Dozens of companies are now vying to make them. The ability to make money off of pharmaceuticals is already uniquely large in the U.S., which lacks the basic price controls other countries have, giving drug companies more freedom over setting prices for their products than anywhere else in the world. During the current crisis, pharmaceutical makers may have even more leeway than usual because of language industry lobbyists inserted into an $8.3 billion coronavirus spending package, passed last week, to maximize their profits from the pandemic. Initially, some lawmakers had tried to ensure that the federal government would limit how much pharmaceutical companies could reap from vaccines and treatments for the new coronavirus that they developed with the use of public funding. But many Republicans opposed adding language to the bill that would restrict the industry's ability to profit, arguing that it would stifle research and innovation. The final aid package not only omitted language that would have limited drug makers' intellectual property rights, it specifically prohibited the federal government from taking any action if it has concerns that the treatments or vaccines developed with public funds are priced too high.
Note: For glaring examples of how big Pharma and select public officials made money hand over fist during previous virus scares, see concise summaries of deeply revealing news articles on the avian and swine flu from reliable major media sources.
The goal of this project is to improve the quality of vaccination programs by improving the quality of physician adverse vaccine event detection and reporting to the national Vaccine Adverse Event Reporting System (VAERS). Restructuring at CDC and consequent delays in terms of decision making have made it challenging despite best efforts to move forward. Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA). Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of "problem" drugs and vaccines that endanger public health. New surveillance methods for drug and vaccine adverse effects are needed. Barriers to reporting include a lack of clinician awareness, uncertainty about when and what to report, as well as the burdens of reporting: reporting is not part of clinicians' usual workflow, takes time, and is duplicative. Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation.
Note: The U.S. government here is admitting that less than 1% of vaccine injuries are reported. What does this say about the safety of vaccines in general? For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
In India – where the Delta variant was first identified and caused a huge outbreak – cases have plunged over the past two months. A similar drop may now be underway in Britain. There is no clear explanation for these declines. In the U.S., cases started falling rapidly in early January. The decline began before vaccination was widespread and did not follow any evident changes in Americans' Covid attitudes. This spring, caseloads were not consistently higher in parts of the U.S. that had relaxed masking and social distancing measures (like Florida and Texas) than in regions that remained vigilant. Large parts of Africa and Asia still have not experienced outbreaks as big as those in Europe, North America and South America. How do we solve these mysteries? Michael Osterholm, who runs an infectious disease research center at the University of Minnesota, suggests that ... Americans should not assume that Delta is destined to cause months of rising caseloads. Nor should they assume that a sudden decline, if one starts this summer, fits a tidy narrative that attributes the turnaround to rising vaccination and mask wearing. We are certainly not powerless in the face of Covid. We can reduce its risks, just as we can reduce the risks from driving, biking, swimming and many other everyday activities. But we cannot eliminate them. "We're not in nearly as much control as we think are," Osterholm said.
Note: For strong evidence that Ivermectin use is one significant cause of the major drop in India, see this webpage. And Sweden, which was hit hard in the beginning of the pandemic yet has never instituted a lockdown or mandated masks, is doing better than the U.S. and most European countries. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Scientists who studied a big COVID-19 outbreak in Massachusetts concluded that vaccinated people who got so-called breakthrough infections carried about the same amount of the coronavirus as those who did not get the shots. Health officials on Friday released details of that research, which was key in this week's decision by the Centers for Disease Control and Prevention to recommend that vaccinated people return to wearing masks indoors. The authors said the findings suggest the CDC's mask guidance should be expanded to include the entire country, even outside of hot spots. The findings have the potential to upend past thinking about how the disease is spread. Previously, vaccinated people who got infected were thought to have low levels of virus and to be unlikely to pass it to others. But the new data shows that is not the case with the delta variant. The outbreak in Provincetown – a seaside tourist spot on Cape Cod in the county with Massachusetts' highest vaccination rate – has so far included more than 900 cases. About three-quarters of them were people who were fully vaccinated. Leaked internal documents ... suggest the CDC may be considering other changes in advice on how the nation fights the coronavirus, such as recommending masks for everyone and requiring vaccines for doctors and other health workers. People with breakthrough infections make up an increasing portion of hospitalizations and in-hospital deaths among COVID-19 patients.
Note: Read also about a surge in reports of serious injuries after receiving COVID injections. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren't profiteering from their monopolies on COVID-19 vaccines, campaigners from The People's Vaccine Alliance said today. New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production. Colombia, for example, has potentially overpaid by as much as $375 million for its doses of the Pfizer/BioNTech and Moderna vaccines, in comparison to the estimated cost price. Despite a rapid rise in COVID cases and deaths across the developing world, Pfizer/BioNTech and Moderna have sold over 90 percent of their vaccines so far to rich countries, charging up to 24 times the potential cost of production. Neither company have agreed to fully transfer vaccine technology and know-how with any capable producers in developing countries, a move that could increase global supply, drive down prices and save millions of lives. Analysis of production techniques for the leading mRNA type vaccines produced by Pfizer/BioNTech and Moderna â€•which were only developed thanks to public funding to the tune of $8.3 billionâ€• suggest these vaccines could be made for as little as $1.20 a dose. Yet COVAX, the scheme set up to help countries get access to COVID vaccines, has been paying, on average, nearly five times more.
The vaccination drive is lagging far behind in many Amish communities. In Ohio's Holmes County, home to the nation's largest concentration of Amish, just 14% of the county's overall population is fully vaccinated. While their religious beliefs don't forbid them to get vaccines, the Amish are generally less likely to be vaccinated for preventable diseases such as measles and whooping cough. Though vaccine acceptance varies by church district, the Amish often rely on family tradition and advice from church leaders, and a core part of their Christian faith is accepting God's will in times of illness or death. Many think they don't need the COVID-19 vaccine now because they've already gotten sick and believe their communities have reached herd immunity, according to health care providers in Ohio, Pennsylvania and Indiana, home to nearly two-thirds of the estimated 345,000 Amish in the U.S.. "That's the No. 1 reason we hear," said Alice Yoder, executive director of community health at Penn Medicine Lancaster General Health, a network of hospitals and clinics. Experts say the low vaccination rates are a reflection of both the nature of the Amish and the general vaccine hesitancy found in many rural parts of the country. Some health clinics that serve the Amish are hesitant to push the issue for fear of driving them away from getting blood pressure checks and routine exams.
Note: This NPR affiliate article states, "Holmes County in northeastern Ohio has the worst vaccination rate in the state – just 17% – and yet, the county has the state's lowest rate of COVID spread." As of Oct. 1, Holmes County had the second lowest COVID case rate in Ohio. Despite having one of the lowest vaccination rates in the US and not observing the lockdown, the number of total per capita deaths in Holmes county is only about 27% more than that of the U.S.. This five-minute video explains why the Amish don't want vaccines.
Freedom of Information Act requests are rarely speedy, but when a group of scientists asked the federal government to share the data it relied upon in licensing Pfizer's COVID-19 vaccine, the response went beyond typical bureaucratic foot-dragging. As in 55 years beyond. That's how long the Food & Drug Administration in court papers this week proposes it should be given to review and release the trove of vaccine-related documents responsive to the request. If a federal judge in Texas agrees, plaintiffs Public Health and Medical Professionals for Transparency can expect to see the full record in 2076. The 1967 FOIA law requires federal agencies to respond to information requests within 20 business days. Justice Department lawyers representing the FDA note in court papers that the plaintiffs are seeking a huge amount of vaccine-related material – about 329,000 pages. The plaintiffs, a group of more than 30 professors and scientists ... filed suit in September in U.S. District Court for the Northern District of Texas, seeking expedited access to the records. But the FDA can't simply turn the documents over. The records must be reviewed to redact "confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients who participated in clinical trials," wrote DOJ lawyers. To meet the plaintiffs' proposed FOIA deadline, the FDA would have to process a daunting 80,000 pages a month. But the plaintiffs note that the FDA has 18,000 employees and a budget of $6 billion.
Note: If big Pharma cares more about stopping the virus than money, why are they hiding "proprietary" information. Why not a worldwide effort to work together to avoid millions of deaths? Apparently profits are more important than saving lives. And why did no significant media pick up this highly revealing news? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Pfizer expects to sell $15 billion worth of Covid-19 vaccines in 2021. That would make it the second-highest revenue-generating drug anytime, anywhere, according to industry reports. The maker of the first Covid-19 vaccine to be approved for use in advanced markets has released its earning forecasts for 2021 today. Pfizer expects to earn between $59 billion and $61 billion - up from $42 billion it made in 2020. Sales of the vaccine are set to bring in about a fourth of Pfizer's total revenue this year. That would be nearly as much as its three best-selling products combined. The company is expecting profit margins for the vaccine to be between 25% and 30% which means profits from the vaccine could be around $4 billion. All of Pfizer's costs and profits from the vaccine are split evenly with BioNTech, the biotech company that helped develop the treatment. There are is only one drug in the world that sells more - Humira, a prescription medication for arthritis. Pfizer plans on selling 2 billion doses of the vaccine this year, but that demand should subside in coming years so the revenue of Covid-19 vaccine won't be stable, Pfizer's CEO Albert Bourla said on an call with analysts and investors. The company expects to continue profiting from it by selling booster doses, including ones required to shield against new variants of the virus, Bourla said. Further, Pfizer is pursuing more avenues to employ the mRNA technology underlying the vaccine, including a flu vaccine and other therapeutic applications.
Note: Read more in this revealing Reuters article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma profiteering from reliable major media sources.
Two weeks ago, with no outcomes data on COVID-19 booster shots for 5-to-11-year-olds, the Centers for Disease Control (CDC) vigorously recommended the booster for all 24 million American children in that age group. The CDC cited a small Pfizer study of 140 children that showed boosters elevated their antibody levels–an outcome known to be transitory. When that study concluded, a Pfizer spokesperson said it did not determine the efficacy of the booster in the 5-to-11-year-olds. But that didn't matter to the CDC. Seemingly hoping for a different answer, the agency put the matter before its own kangaroo court of curated experts, the Advisory Committee on Immunization Practices (ACIP). Committee members ... emphasized the importance of a universal booster message that applies to all age groups. Most remarkably, it didn't seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The Food and Drug Administration last week authorized Americans 50 and over to get a fourth Covid vaccine dose. Some of the FDA's own experts disagree with the decision, but the agency simply ignored them. Eric Rubin, editor in chief of the New England Journal of Medicine, sits on the advisory committee. He told CNN last month that he hadn't seen enough data to determine whether anyone needs a fourth dose whose immune system isn't seriously deficient. At the crux of the broad opposition to second boosters is the recognition of B- and T-cells, which public-health officials have long ignored. They talk only about antibody levels, which tend to decline in the months after vaccination. B- and T-cells, activated by the primary vaccine series or an infection ... are highly and durably effective at preventing serious illness from Covid. An additional vaccine dose induces a fleeting high in antibody levels, offering only mild and short-lived protection. Two top FDA officials quit the agency in September complaining of undue pressure to authorize boosters. Marion Gruber, former director of the Office of Vaccine Research and Review, and her deputy, Philip Krause, later wrote about the lack of data to support a broad booster authorization. Hours after the FDA authorized the fourth dose, the Centers for Disease Control and Prevention gave its formal approval to the move–also without convening its external vaccine experts.
Note: To read the full article without a subscription, see this webpage. Read Prof. Mark Skidmore's eye-opening study titled "How Many People Died from the Covid-19 Inoculations?" For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
We used COVID-19 data provided by the Our World in Data for cross-country analysis, available as of September 3, 2021. We included 68 countries that met the following criteria: had second dose vaccine data available; had COVID-19 case data available; had population data available; and the last update of data was within 3 days prior to or on September 3, 2021. For the 7 days preceding September 3, 2021 we computed the COVID-19 cases per 1 million people for each country as well as the percentage of population that is fully vaccinated. At the country-level, there appears to be no discernable relationship between percentage of population fully vaccinated and new COVID-19 cases in the last 7 days. In fact, the trend line suggests a marginally positive association such that countries with higher percentage of population fully vaccinated have higher COVID-19 cases per 1 million people. Notably, Israel with over 60% of their population fully vaccinated had the highest COVID-19 cases per 1 million people in the last 7 days. The lack of a meaningful association between percentage population fully vaccinated and new COVID-19 cases is further exemplified, for instance, by comparison of Iceland and Portugal. Both countries have over 75% of their population fully vaccinated and have more COVID-19 cases per 1 million people than countries such as Vietnam and South Africa that have around 10% of their population fully vaccinated.
Note: Learn more about these eye-opening findings on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A tremendous number of government and private policies affecting kids are based on one number: 335. That is how many children under 18 have died with a Covid diagnosis code in their medical record, according to the Centers for Disease Control and Prevention. Yet the CDC, which has 21,000 employees, hasn't researched each death to find out whether Covid caused it or if it involved a pre-existing medical condition. Without these data, the CDC Advisory Committee on Immunization Practices decided in May that the benefits of two-dose vaccination outweigh the risks for all kids 12 to 15. I've written hundreds of peer-reviewed medical studies, and I can think of no journal editor who would accept the claim that 335 deaths resulted from a virus without data to indicate if the virus was incidental or causal. Johns Hopkins worked with the nonprofit FAIR Health to analyze approximately 48,000 children under 18 diagnosed with Covid in health-insurance data. Our report found a mortality rate of zero among children without a pre-existing medical condition. The National Education Association has been debating whether to urge schools to require vaccination before returning to school in person. How can they or anyone debate the issue without the right data? Meanwhile ... Alameda County, Calif., reduced its Covid death toll by 25%. after state public-health officials insisted that deaths be attributed to Covid only if the virus was a direct or contributing factor
Note: Alameda County corrected their COVID death figures, but how many other counties throughout the US did not? If you can't access this article on the WSJ website, go to this webpage. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
In the coming months, Linda Thomas-Greenfield, President Joe Biden's ambassador to the United Nations, will hear from a growing chorus of developing nations about the foundering efforts to distribute the coronavirus vaccine globally. The nations, many of which have not even begun vaccinating their populations, are demanding that the U.S. support proposals to temporarily waive certain patent and intellectual property rights so that generic coronavirus vaccines can be produced. The proposals have been fiercely opposed by American drugmakers, including Pfizer. ASG ... represents Pfizer. Many leading figures in Biden's administration, including key White House advisers, State Department leaders, and health care officials have financial stake in or professional ties to vaccine manufacturers, which are now lobbying to prevent policies that would cut into future profits over the vaccine. ASG in particular has unusual amounts of sway in the Biden administration. State Department officials Victoria Nuland, Wendy Sherman, Uzra Zeya, and Molly Montgomery previously worked at ASG, as did Philip Gordon, Vice President Kamala Harris's national security adviser. The pharmaceutical industry, in a bid to shield an expected financial windfall, has pressed the Biden administration not only to oppose the waiver, but also to impose trade-related sanctions on countries that back [a] proposal or move to manufacture coronavirus vaccines without permission from patent holders.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.